Filter
1439
Text search:
drug
regimens
Featured
Recommendations
165
New Publications
351
Language
Document type
No document type
899
Guidelines
219
Studies & Reports
191
Manuals
46
Strategic & Response Plan
31
Fact sheets
23
Training Material
16
Situation Updates
7
Resource Platforms
3
Infographics
3
Online Courses
1
Countries / Regions
India
77
South Africa
45
Global
39
Kenya
38
Tanzania
34
Western and Central Europe
30
Zambia
27
Ethiopia
26
Uganda
25
Eastern Europe
25
Nepal
22
Latin America and the Carribbean
19
Nigeria
18
Malawi
18
Rwanda
17
Namibia
17
Africa
17
Asia
16
Bangladesh
14
Myanmar / Burma
14
Ukraine
13
Ghana
12
Zimbabwe
12
Philippines
12
South–East Asia Region
11
Cambodia
10
Mozambique
10
Lesotho
9
Liberia
8
Russia
8
Sierra Leone
7
Botswana
7
Cameroon
5
Haiti
5
Eswatini/ Swaziland
5
Colombia
5
Georgia
5
Senegal
4
Congo, Democratic Republic of
4
Thailand
4
East and Southern Africa
4
Venezuela
4
Albania
4
USA
3
Pakistan
3
Syria
3
Indonesia
3
Argentina
3
West and Central Africa
3
Western Pacific Region
3
Tajikistan
3
Estonia
3
Vietnam
3
Somalia
2
South Sudan
2
Germany
2
China
2
Brazil
2
Sri Lanka
2
Eastern Europe and Central Asia
2
Bhutan
2
Timor Leste/ East Timor
2
Romania
2
North America
2
Guinea
1
Burkina Faso
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Gambia
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
Peru
1
North Macedonia
1
Bolivia
1
Greece
1
Chile
1
Paraguay
1
North Korea
1
Laos
1
Iran
1
Jamaica
1
Denmark
1
Tunisia
1
Oman
1
Authors & Publishers
Publication Years
Category
Countries
468
Clinical Guidelines
222
Public Health
60
Women & Child Health
52
Capacity Building
31
Key Resources
15
Pharmacy & Technologies
14
Toolboxes
HIV
309
TB
305
NTDs
62
AMR
50
Pharmacy
41
Malaria
31
NCDs
30
COVID-19
23
Mental Health
22
Ebola & Marburg
18
Refugee
18
Polio
11
Conflict
11
Caregiver
7
Disability
6
Rapid Response
6
Natural Hazards
4
Health Financing Toolbox
4
Planetary Health
3
Specific Hazards
2
Global Health Education
2
Social Ethics
2
2.0 Rapid Response
2
Cholera
1
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an
...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens
...
This e-course will guide you through the essentials of latest existing WHO guidelines and policy recommendations on drug-resistant TB. You will also learn more about the rationale behind the WHO recommendations for the management of DR-TB, implement
...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral
...
This study aimed to understand the patterns of HIV drug resistance in pregnant women in Mozambique. This might help in tailoring optimal regimens for prevention of mother to child transmission of HI
...
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and a
...
The protozoan parasite Trypanosoma cruzi causes Chagas disease, an important public health problem throughout Latin America. Current therapeutic options are characterised by limited efficacy, long treatment regimens and frequent toxic side-effects.
...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evi
...
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Better drug regimens for mass drug administration (MDA) could accelerate the Global Programme to Eliminate Lymphatic Filariasis (LF). This communi
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to
...
The "Pocket Manual for the Diagnosis and Treatment of Malaria", published by the Ministry of Health of the Sultanate of Oman, provides practical guidance for healthcare professionals on how to identify, manage, and treat malaria cases. It emphasizes parasitological confirmation before treatment, out
...
Combination therapy is a cornerstone of modern malaria treatment, particularly in the context of widespread multidrug resistance. Using two or more antimalarial drugs with different mechanisms simultaneously enhances efficacy, shortens treatment duration, improves compliance and delays the developme
...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the
...
Policy brief. July 2020
